Scientific Advisory Board, and R&D Counsel
-

Neil Kumar
CEO and co-founder of BridgeBio Pharma
-

Yael Weiss
CEO of Mahzi Therapeutic
-

Katherin Meyer
Chief Scientific Officer, Alcyone Therapeutics
-

Justin To
CEO at QED Therapeutics, a BridgeBio company
-

Clayton Beard
CSO and Site Head at BridgeBio Gene Therapy
-

Orrin Devinsky
Neurosurgeon, NYU Langone, Chief of Service, NYU Epilepsy
-

Eric Marsh MD, PhD.
Professor of Neurology and Pediatrics at University of Pennsylvania School of Medicine; Neurologist CHOP, Clinical Director Orpahn Disease Center
-

Tim Benke MD, PhD.
Professor Pediatrics, Neurology, and Pharmacology at University of Colorado School of Medicine, Neurologist Colorado Children's Hospital
-

Heather Olson MD, PhD
Professor of Neurology Harvard Medical School, Neurologist Boston Children's Hosptial
-

Nadia Nahi-Buisson MD, PhD.
Pediatric Neurologist and Professor, Necker Enfants Malades University Hospital
-

Karen Malone
Director at Leiden Analytics
-

Floorje van Nooten, PhD
VP Market Access & Commercialization Expert
-

Xilma Ortiz-Gonzalez, M.D., Ph.D.
Pediatric Neurologist, CHOP, Neurology Instructor, University of Pennsylvania
-

Pam Ventola
Chief Science Officer, Cogstate; Associate Professor Yale Child Study Center
-

Hourinaz Behesti, PhD
CEO Hebbian Bio
-

Monica Coenraads
Founder, CEO, Rett Syndrome Research Trust
-

Allyson Berent
Chief Scientific Officer, Foundation Angelman Syndrome Therapeutics (FAST)
-

Terry Pirovolakis
CEO & Founder, Elpida Therapeutics
-

Scott Dindot Ph.D.
Assistant Professor, Texas A&M College of Medicine
-

Mark Pykett, Ph.D.
CEO, Orogen Therapeutics